Gero Competitors and Similar CompaniesClear all
Gero's competitors and similar companies include Aqemia, Zentalis Pharmaceuticals and Sanofi Genzyme.
 Gero Gero is a biotechnology company intended to evaluate the personal risks of mortality and health. |  Sanofi Genzyme Sanofi Genzyme (also known as Genzyme Corporation) is a biotech company that specializes in rare diseases, rare blood disorders, multiple sclerosis, oncology, and immunology. | |||
Founding Date | Founding Date 2015 | Founding Date 2019 | Founding Date 2014 | Founding Date 1981 |
Type | Type Private | Type Private | Type Public | Type Subsidiary |
Tags | ||||
Locations | Locations Singapore, SG HQ Agios Athanasios, CY Moskva, RU | Locations Paris, FR HQ Paris, FR | Locations New York, US HQ San Diego, US | Locations Cambridge, US HQ Macquarie Park, AU Malaga, AU Virginia, AU São Paulo, BR Mississauga, CA Toronto, CA see more |
Employees | Employees 105 | Employees 783% increase | Employees 62520% increase | Employees 9,9041% decrease |
Funding | ||||
Latest funding round | Latest funding round $ 2.2m (almost 6 years ago) | Latest funding round $ 1.1m (over 6 years ago) | Latest funding round N/A | Latest funding round N/A |
Total funding raised | Total funding raised $ 7.5m | Total funding raised $ 1.1m | Total funding raised $ 119m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Aqemia
HQ
Paris, FR
Employees
78↑ 3% increase
Aqemia is a company that develops molecule matching technology.
View company
Zentalis Pharmaceuticals
HQ
New York, US
Employees
62
Zentalis is a biopharmaceutical company.
View companySanofi Genzyme
HQ
Cambridge, US
Sanofi Genzyme (also known as Genzyme Corporation) is a biotech company that specializes in rare diseases, rare blood disorders, multiple sclerosis, oncology, and immunology.
View company